Tacrolimus: Clinical Trials

12 trials for Tacrolimus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 5 unknown, 1 enrolling by invitation, 1 recruiting. 3 Phase 3, 2 Phase 1, 1 Early Phase 1, 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 12Completed 1, Unknown 1
Early Phase 11Enrolling by invitation 1
Not applicable1Unknown 1
Phase 21Unknown 1
Phase 41Recruiting 1

Follow Tacrolimus: new trials by email Literature Review of Tacrolimus trials Research Report on Tacrolimus

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGO
Tacrolimus, Calcipotriol - Vitiligo - Macular Depigmentation, Tacrolimus
Early Phase 1Enrolling by invitationDr ayesha wahid602025-05-012025-06-24
Model Informed preciSion doSIng tO iNdividualise and Optimize Pharmacotherapeutic Treatment
venipuncture - Pharmacokinetics, Area Under Curve
CompletedRadboud University Medical Center292024-03-152025-12-02
Study on the Application of Hyperspectral Imaging Technique in the Treatment of IMN by TAC
Tacrolimus for the treatment of IMN - Idiopathic Membranous Nephropathy, Tacrolimus
UnknownQianfoshan Hospital402023-04-252023-04-04
Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations
Tacrolimus, Immediate Release, Oral, Tacrolimus Extended Release Oral Tablet - Liver Transplantation, Immunosuppression
Phase 4RecruitingUniversity of British Columbia1242023-01-092024-01-02
Population Pharmacokinetics of Tacrolimus in Nephrotic Syndrome
Tacrolimus - Nephrotic Syndrome, Tacrolimus
UnknownThe Third Xiangya Hospital of Central South University2002019-08-102019-08-05
Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy
Tacrolimus, Prednisone - Tacrolimus, Idiopathic Membranous Nephropathy
Not applicableUnknownXinhua Hospital, Shanghai Jiao Tong University School of Medicine1242018-11-262019-06-25
Dermatologic Tacrolimus Ointment on Eyelids in the Treatment of Refractory Vernal Keratoconjunctivitis and Atopic Keratoconjunctivitis
Vernal Keratoconjunctivitis, Atopic Keratoconjunctivitis
UnknownNational Taiwan University Hospital102018-06-012018-06-14
Effectivness of Topical Tacrolimus Monotherapy in Patients With Vitiligo
Tacrolimus 0.03% Ointment, Hydrocortisone Acetate 1% Ointment - Vitiligo, Tacrolimus
Phase 1 / Phase 2UnknownSohag University1002017-10-012017-11-30
Improving Medication-taking After Liver Transplant
Telemetric - Nonadherence, Tacrolimus
Phase 1CompletedIcahn School of Medicine at Mount Sinai72014-08-012016-07-01
a Comparative Pharmacokinetic Study of Two Oral Formulations of Tacrolimus in Renal Allograft Recipients
Tacrolimus - Pharmacokinetics, Tacrolimus
Phase 3CompletedSeoul National University Hospital802008-09-012015-05-27
Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus Nephritis
tacrolimus (FK506), cyclophosphamide or azathioprine - Kidney Diseases, Lupus Nephritis
Phase 3CompletedSun Yat-sen University812006-07-012008-10-29
Prospective, Multicenter Study of the Efficacy and Tolerance of Tacrolimus on Refractory Nephrotic Syndrome (RNS)
tacrolimus (FK506) - Kidney Diseases, Nephrotic Syndrome
Phase 3CompletedSun Yat-sen University612006-06-012016-04-20

Narrower conditions

Glomerulonephritis, Membranous (2)  ·  Kidney Diseases (2)  ·  Nephrotic Syndrome (2)  ·  Vitiligo (2)  ·  Conjunctivitis, Allergic (1)  ·  Lupus Nephritis (1)  ·  Neurotoxicity Syndromes (1)  ·  Patient Compliance (1)  ·  Tremor (1)

Broader conditions

Female Urogenital Diseases (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Male Urogenital Diseases (5)  ·  Urogenital Diseases (5)  ·  Urologic Diseases (5)  ·  Immune System Diseases (4)  ·  Autoimmune Diseases (3)  ·  Glomerulonephritis (3)  ·  Kidney Diseases (3)  ·  Nephritis (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Hypopigmentation (2)  ·  Nephrosis (2)  ·  Pigmentation Disorders (2)  ·  Skin Diseases (2)

Interventions

Tacrolimus (9)  ·  Azathioprine (1)  ·  Cyclophosphamide (1)  ·  Ointments (1)  ·  Phlebotomy (1)  ·  Prednisone (1)  ·  calcipotriene (1)  ·  hydrocortisone acetate (1)

Sponsors

Sun Yat-sen University (2)  ·  Dr ayesha wahid (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  National Taiwan University Hospital (1)  ·  Qianfoshan Hospital (1)  ·  Radboud University Medical Center (1)  ·  Seoul National University Hospital (1)  ·  Sohag University (1)  ·  The Third Xiangya Hospital of Central South University (1)  ·  University of British Columbia (1)  ·  Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (1)

Countries

China (2)  ·  Canada (1)  ·  Egypt (1)  ·  Netherlands (1)  ·  Pakistan (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  United States (1)

Top investigators

Jian Chen, MD (2)  ·  Ping Fu, MD (2)  ·  Wei Shi, MD (2)  ·  Eyal Shemesh, MD (1)  ·  I-Jong Wang, professor (1)  ·  Jo-Ann Ford, RN (1)  ·  Jongwon Ha, MD, PhD (1)  ·  Junzhou Fu, MD (1)  ·  Nynke Jager, Dr (1)  ·  Ramadan Saleh, MD (1)  ·  Tan Qi Lou, MD (1)  ·  Tanqi Lou, MD (1)  ·  Trana Hussaini, Pharm D (1)

Results publications

PMID 21177013, PMID 42814375